Lee Ho-Su, Choe Jaewon, Lee Hyo Jeong, Hwang Sung Wook, Park Sang Hyoung, Yang Dong-Hoon, Kim Kyung-Jo, Ye Byong Duk, Byeon Jeong-Sik, Myung Seung-Jae, Yoon Yong Sik, Yu Chang Sik, Kim Jin-Ho, Yang Suk-Kyun
Health Screening and Promotion Center, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Intest Res. 2016 Jul;14(3):258-63. doi: 10.5217/ir.2016.14.3.258. Epub 2016 Jun 27.
BACKGROUND/AIMS: Accurately diagnosing inflammatory bowel disease (IBD) remains a challenge, but is crucial for providing proper management for affected patients. The aim of the present study was to evaluate the frequency of change in diagnosis in Korean patients who were referred to our institution with a diagnosis of IBD.
We enrolled 1,444 patients diagnosed with ulcerative colitis (UC) and 1,452 diagnosed with Crohn's disease (CD), who had been referred to the Asan Medical Center between January 2010 and December 2014. These patients were assessed and subsequently classified as having UC, CD, indeterminate colitis, possible IBD, or non-IBD.
During a median follow-up of 15.9 months, 400 of the 2,896 patients (13.8%) analyzed in this study experienced a change in diagnosis. A change in diagnosis from UC to CD, or vice-versa, was made in 24 of 1,444 patients (1.7%) and 23 of 1,452 patients (1.6%), respectively. A change to a non-IBD diagnosis was the most common modification; 7.5% (108 of 1444) and 12.7% (184 of 1452) of the patients with a referral diagnosis of UC and CD, respectively, were reclassified as having non-IBD. Among the 292 patients who were ultimately determined not to have IBD, 135 (55 UC and 80 CD cases) had received IBD-related medication.
There are diagnostic uncertainties and difficulties in relation to IBD. Therefore, precise assessment and systematic follow-up are essential in the management of this condition.
背景/目的:准确诊断炎症性肠病(IBD)仍然是一项挑战,但对于为受影响患者提供适当治疗至关重要。本研究的目的是评估被转诊至我院并诊断为IBD的韩国患者的诊断变化频率。
我们纳入了2010年1月至2014年12月期间被转诊至峨山医疗中心的1444例诊断为溃疡性结肠炎(UC)的患者和1452例诊断为克罗恩病(CD)的患者。对这些患者进行评估,随后分类为患有UC、CD、不确定性结肠炎、可能的IBD或非IBD。
在中位随访15.9个月期间,本研究分析的2896例患者中有400例(13.8%)经历了诊断变化。1444例患者中有24例(1.7%)诊断从UC变为CD,或反之,1452例患者中有23例(1.6%)。最常见的诊断变化是变为非IBD诊断;转诊诊断为UC和CD的患者中,分别有7.5%(1444例中的108例)和12.7%(1452例中的184例)被重新分类为非IBD。在最终确定未患IBD的292例患者中,135例(55例UC和80例CD病例)曾接受过IBD相关药物治疗。
IBD存在诊断不确定性和困难。因此,精确评估和系统随访对于该病的管理至关重要。